Healthcare
TA Associates' Solabia Group buys Algatech
TA has been a minority investor in natural active ingredients manufacturer Solabia since 2018
ArchiMed carves out Diesse from PZ Cormay
Diesse was acquired from Orphée, the Swiss subsidiary of Warsaw-listed diagnostics group PZ Cormay
Sofinnova closes MD Start III Fund on €48m
MD Start, which is a group of three funds, was started by Sofinnova Partners in 2010
VCs invest £14m in Storm Therapeutics
Storm Therapeutics has now raised more than £30m in capital from its new and existing investors
Syncona leads £35m series-A for Quell
UCL Technology Fund also took part in the round for the newly launched cell therapy company
BIVF, UCB Ventures lead £1.4m round for Rinri
Representatives from BIVF, UCB Ventures and BioCity have joined the company's board of directors
LSP et al. back $38.5m series-B for DNA Script
Illumina Ventures, M Ventures, Sofinnova, Kurma and Idinvest recommit to DNA Script
Apposite's Swanton bolts on GRS and Values In Care
Deal comes four months after the group acquired residential childcare provider Courtyard Care
SHS invests in Betterguards
Betterguards is SHS's third investment from SHS V, which held its first close in 2018 on €90m
Yabeo-backed CommitMed merges with Prosenio
Prosenio, the merged company, will generate more than €16m in sales and will employ 60 people
VCs sell Therachon to Pfizer for $810m
Pfizer will acquire Therachon for $340m with $470m in additional, conditional payments
Ampersand takes minority stake in GenDX
Ampersand typically invests $10-50m in companies with $10-100m in annual revenue
BioGeneration, Wellington lead €30m series-A for Confo
Fund+ and Perceptive Advisors, Capricorn, Qbic, PMV, Mints, V-Bio Ventures and VIB joined the round
Longship-backed Sensio acquires Vestfold Audio
Combined group is majority owned by Longship, employs 75 people and projects revenues of NOK 150m
Panakès Partners in CHF 9.5m round for SamanTree
Panakès Partners is using equity from its Fund I, which invests €5-6m in European startups
Gimv establishes life sciences advisory board
Gimv has made more than 80 investments in the life sciences segment since it started in 1982
Consortium invests CHF 12.5m in Alentis
BioMedPartners, BB Pureos Bioventures, BPI France, Schroder Adveq and HTGF participate in the deal
Abénex sells Cisbio Bioassays to trade
Abénex exits France-based biotechnology company Cisbio after three years of ownership
Bowmark sells Care Fertility to Silverfleet
Earlier reports suggested the fertility clinic group could attract bids of around 8x its £11m EBITDA
LDC backs Duncan & Todd's bolt-on of Black & Lizars sites
Transaction sees the opticians group acquiring nine stores from the optometrists chain
PAI's Ethypharm bolts on Pharmy II Laboratory
Ethypharm acquires pharmaceutical laboratory specialising in the treatment of pain
VCs in funding round for Cevec
Peppermint Venture, NRW Bank and Creathor Ventures raised €4.5m for Cevec in 2015
Concerning prognoses for German healthcare
Uncertainty around new regulation in the healthcare sector has caused jitters among investors
Gilde Healthcare sells Stepping Stones to trade
GP ends nine-year ownership of Netherlands-based senior residential care service Stepping Stones